CSPC Pharmaceutical Group's total inventories for the quarter that ended in Dec. 2025 was €375 Mil. CSPC Pharmaceutical Group's average total inventories from the quarter that ended in Sep. 2025 to the quarter that ended in Dec. 2025 was €187 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. CSPC Pharmaceutical Group's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was €0.02.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
CSPC Pharmaceutical Group's Days Inventory for the
three
months ended in Dec. 2025 was 66.98.
Inventory Turnover measures how fast the company turns over its inventory within a year.
CSPC Pharmaceutical Group's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.36.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CSPC Pharmaceutical Group's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.25.
CSPC Pharmaceutical Group (FRA:CVGU) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
CSPC Pharmaceutical Group's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CSPC Pharmaceutical Group's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
CSPC Pharmaceutical Group Total Inventories Related Terms
CSPC Pharmaceutical Group Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
CSPC Pharmaceutical Group (FRA:CVGU) has a Total Inventories of €375 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for CSPC Pharmaceutical Group and its competitors.
Is CSPC Pharmaceutical Group's Total Inventories too high?
CSPC Pharmaceutical Group's current Total Inventories is €375 Mil. Overall, CSPC Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Total Inventories compare to LLY and JNJ?
CSPC Pharmaceutical Group's Total Inventories of €375 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for CSPC Pharmaceutical Group and its competitors. CSPC Pharmaceutical Group's current Total Inventories is €375 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
CSPC Pharmaceutical Group (FRA:CVGU) has a current Total Inventories of €375 Mil. The stock's GF Value™ is €2.72, compared to a current price of €2.74 — trading 0.7% above its estimated fair value. The current Total Inventories is €375 Mil. CSPC Pharmaceutical Group's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For CSPC Pharmaceutical Group (FRA:CVGU), the current Total Inventories is €375 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSPC Pharmaceutical Group (FRA:CVGU) Overvalued in 2026?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued.
The current stock price of €2.74 is trading 0.7% above its estimated GF Value™ of €2.72.
Key valuation signals for FRA:CVGU:
Total Inventories: €375 Mil
GF Value™: €2.72 vs. price of €2.74 (0.7% above fair value)
No single metric tells the full story. See the FRA:CVGU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
88GF Score
Get the complete analysis for FRA:CVGU
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CVGU has been successfully added to your 
